NCT05878899View on ClinicalTrials.gov

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

77

Participants

Timeline

Start Date

May 3, 2022

Primary Completion Date

March 13, 2023

Study Completion Date

March 13, 2023

Conditions

Venous Thromboembolism

Interventions

DRUG

Enoxaparin

Prophylactic dose of enoxaparin once daily for 10 days after delivery.

Trial Locations (1)

1205

Geneva University Hospitals, Geneva

All Listed Sponsors

lead

University Hospital, Geneva

OTHER